AU
UK
CA
NZ
IND
US
Autolus Therapeutics plc (NASDAQ:AUTL) announced that the National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending AUCATZYL (obecabtagene autoleucel) for adults aged 26 years and older with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL). With this decision, …
Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi (NASDAQ:SNY) announced that the European Commission has approved Dupixent (dupilumab) for the treatment of moderate-to-severe chronic spontaneous urticaria (CSU) in adults and adolescents aged 12 years and older who do not respond adequately to histamine-1 antihistamines and are naïve …
Asia-Pacific markets traded mixed on Tuesday as a rebound in Wall Street’s major tech names lifted overall sentiment. The turnaround in US markets was powered largely by Alphabet (NASDAQ:GOOGL), which gained 6.30% on Monday after unveiling its upgradedAImodel, Gemini 3. The enhanced model renewed …
Constellation Brands, Inc. (NYSE:STZ) is a global producer and marketer of beer, wine, and spirits, operating across the United States, Mexico, New Zealand, and Italy. Its portfolio includes well-known brands such as Corona Extra, Modelo Especial, Robert Mondavi Winery, Kim Crawford, The Prisoner Wine …
Rosenblatt Securities has reaffirmed a“neutral”rating on Arista Networks (NYSE:ANET) in its latest research communication. The brokerage has assigned aUSD 140price objective, reflecting a cautious approach following the company’s recently releasedearnings resultsand updated guidance.
Market Movers:On Friday, the top gainers were Foxx Development Holdings Inc. (+75.16%), followed by Mobile-health Network Solutions (+56.25%). On the contrary Mawson Infrastructure Group Inc. (-39.34%), and Geospace Technologies Corporation (-25.90%) declined the most the same day.
Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company advancing a cell-based platform for the targeted delivery of therapeutic payloads in oncology, has released new data from its ongoing TEM-GBM study in newly diagnosed glioblastoma multiforme patients with an unmethylated MGMT promoter. As of the …
Stagwell (NASDAQ:STGW) has announced its new Asia-Pacific headquarters in Singapore, located at Solaris @ one north, a Green Mark Platinum-certified development within the city’s innovation district. Opening in Q1 2026, the new hub reinforces the company’s ambition to deepen its presence across APAC while …
Clarivate (NYSE:CLVT) has launched Derwent Patent Monitor, an enterpriseAIsolution aimed at transforming intellectual property and research teams to conduct collaborativepatentreviews. The platform is designed to speed up high-stakes decisions such as determining patentability, assessing freedom to operate, and evaluating opposition or assertion scenarios.
Sangamo Therapeutics (NASDAQ:SGMO) announced that the U.S.Food and Drug Administrationhas accepted its request for a rollingBiologics License Applicationsubmission for isaralgagene civaparvovec, the company's investigational gene therapy for adults with Fabry disease. A rolling submission allows the FDA to review sections of the application as …
Please wait processing your request...